NCT06336148 2025-10-15A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsActym Therapeutics, Inc.Phase 1 Terminated10 enrolled
NCT02628067 2025-09-22KEYNOTE 158Merck Sharp & Dohme LLCPhase 2 Active not recruiting1,609 enrolled 4 FDA